Tiziana Life Sciences to Present at Jefferies London Healthcare Conference
Ticker: TLSA · Form: 6-K · Filed: Nov 13, 2025 · CIK: 1723069
Sentiment: neutral
Topics: conference-presentation, healthcare, management-update
TL;DR
Tiziana Life Sciences presenting at Jefferies London Healthcare Conference Nov 13th.
AI Summary
Tiziana Life Sciences Ltd announced on November 13, 2025, that its senior leadership team, including CEO Ivor Elrifi and COO/CFO Keeren Shah, will present at the Jefferies London Healthcare Conference. This presentation is expected to provide updates on the company's progress and strategic direction.
Why It Matters
Presenting at a major healthcare conference provides Tiziana Life Sciences with a platform to showcase its developments to investors and industry peers, potentially increasing visibility and interest in the company.
Risk Assessment
Risk Level: medium — Participation in industry conferences can be positive, but the actual impact on stock price depends on the substance of the presentation and market reception.
Key Players & Entities
- Tiziana Life Sciences Ltd (company) — Registrant
- Ivor Elrifi (person) — Chief Executive Officer
- Keeren Shah (person) — Chief Operating Officer/Chief Financial Officer
- Jefferies London Healthcare Conference (company) — Event
- November 13, 2025 (date) — Announcement Date
FAQ
What is the primary purpose of Tiziana Life Sciences' participation in the Jefferies London Healthcare Conference?
The company's senior leadership team will present at the conference, likely to provide updates on the company's progress and strategic direction.
Who will be representing Tiziana Life Sciences at the conference?
Chief Executive Officer Ivor Elrifi and Chief Operating Officer/Chief Financial Officer Keeren Shah will present.
When was this announcement made?
The announcement was made on November 13, 2025.
What is Tiziana Life Sciences' principal executive office address?
The company's principal executive office is located at 9th Floor, 107 Cheapside, London EC2V 6DN.
Does Tiziana Life Sciences file annual reports under Form 20-F?
Yes, the company indicates it files annual reports under cover of Form 20-F.
Filing Stats: 327 words · 1 min read · ~1 pages · Grade level 14.4 · Accepted 2025-11-13 08:30:52
Filing Documents
- ea0265493-6k_tiziana.htm (6-K) — 17KB
- ea026549301ex99-1_tiziana.htm (EX-99.1) — 11KB
- ex99-1_001.jpg (GRAPHIC) — 4KB
- 0001213900-25-109607.txt ( ) — 35KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. TIZIANA LIFE SCIENCES LTD Date: November 13, 2025 By: /s/ Keeren Shah Name: Keeren Shah Title: Chief Financial Officer 2 EXHIBIT INDEX Exhibit No. Description 99.1 Tiziana Life Sciences LTD Press Release, dated November 13, 2025 3